glp-1s weight loss comparison with semaglutide 🧬 vs TIRZEPATIDE vs RETATRUTIDE 🧬 Understanding the difference could help you make more informed decisions about management and metabolic health. 👇 🔹 Semaglutide Targets GLP-1 receptors to help reduce Tirzepatide vs semaglutide: dual GLP-1

Do not abruptly stop taking Qysmia, as this can cause withdrawal reactions

This dual action supports both weight management and overall metabolic health

PlexusDx evaluates your genetic predisposition to sustained weight loss to personalize a discontinuation timeline that works for your metabolism

Short-acting GLP-1RAs (exenatide [ t 1/2 of 2.4 hours] and lixisenatide [ t 1/2 of 24 hours] administered before meals twice-daily and once-daily, respectively) exhibit intermittent GLP-1 receptor activation translating into potent deceleration of upper gastrointestinal motility, an effect which is sustained during prolonged treatment

To learn more about compounded semaglutide, check out this blog